The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase 2, multicenter study of FOLFIRINOX followed by ipilimumab in combination with allogeneic GM-CSF transfected pancreatic tumor vaccine in the treatment of metastatic pancreatic cancer.
Rina Khatri Patel
No relevant relationships to disclose
Andrew H. Ko
No relevant relationships to disclose
Beth Onners
No relevant relationships to disclose
Jennifer N. Uram
No relevant relationships to disclose
Rose Parkinson
No relevant relationships to disclose
Elizabeth Sugar
No relevant relationships to disclose
Eric Lutz
No relevant relationships to disclose
Lei Zheng
No relevant relationships to disclose
Daniel A. Laheru
No relevant relationships to disclose
Elizabeth M. Jaffee
Research Funding - Aduro Biotech
Dung T. Le
Research Funding - Aduro Biotech